Delivery Order 75N95023D00021-75N95025F00002
Award Date 9/21/25
Potential Completion Date 9/20/27
Potential Value $249K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
St Charles, MO, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $132,771.58 firm-fixed-price delivery order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The contract is for receptor profile screening services in support of NIDA's drug abuse research programs. It has a period of performance from June 25, 2025 to June 24, 2026. The contract is not set aside for any small...
- The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...
- The National Institute on Drug Abuse issued a $136,499.26 delivery order to Eurofins Discovery Services North America, LLC on September 1, 2026, for receptor profile screening under a Total Small Business set-aside. Performance runs September 1, 2026 through August 31, 2027, at the awardee's facility in St. Charles, MO. The order is priced firm fixed price. Receptor profile screening supports the Institute's drug abuse research initiatives and involves advanced binding studies and related...
- The National Institute on Drug Abuse issued a delivery order to Eurofins Discovery Services North America, LLC on September 26, 2023, with a ceiling value of $141,140.16 under a Total Small Business set-aside for receptor binding and predictive toxicology services. The order was issued under a $5 million single-award IDIQ with NIDA for receptor binding and predictive toxicology services through September 2028. Place of performance is Bethesda, MD. The period of performance runs from September...
- The U.S. National Institute on Drug Abuse (NIDA) has awarded a firm-fixed-price purchase order contract worth $20,217.10 to Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization. The contract, which does not have a set-aside designation, is for the provision of various research and development services to support NIDA's drug abuse research programs. These services include receptor binding studies, predictive toxicology, safety pharmacology, and non-clinical research....
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
- This is a $20,823.14 firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, to Eurofins Discoverx LLC, a foreign-owned for-profit organization. The purpose is to test 30 compounds for binding to IRAK and FLT3 kinases over a 1-year period of performance from September 16, 2020 to September 15, 2021. This award was made through a non-competitive combined synopsis/solicitation process under simplified acquisition procedures...
- The Food and Drug Administration awarded a $57.8K firm-fixed-price purchase order to Eurofins Discovery Services North America, LLC for protein binding and functional assay services targeting human central nervous system receptors. The contract, designated as a total small business set-aside, was awarded on July 27, 2022, with performance completed by January 31, 2023. Services were performed at Eurofins' facility in St. Charles, Missouri. This award represents a specific delivery order for...
- This is a $140,748 firm fixed price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Eurofins Panlabs, Inc. for receptor binding and predictive toxicology services. The work will be performed in Weldon Spring, Missouri and is not associated with any set-aside designation. Eurofins Panlabs, Inc. is a foreign-owned for-profit contract research organization that has previously provided analytical chemistry,...